Blueprint Medicines Corporation Share Price
Equities
BPMC
US09627Y1091
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
105.2 USD | -1.37% | -1.23% | +14.25% |
05-14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
05-06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
Sales 2024 * | 431M 33.89B | Sales 2025 * | 653M 51.36B | Capitalization | 6.68B 526B |
---|---|---|---|---|---|
Net income 2024 * | -152M -11.96B | Net income 2025 * | -104M -8.18B | EV / Sales 2024 * | 14.3 x |
Net cash position 2024 * | 514M 40.44B | Net cash position 2025 * | 444M 34.96B | EV / Sales 2025 * | 9.55 x |
P/E ratio 2024 * |
-47.9
x | P/E ratio 2025 * |
-65
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.94% | Free-Float | 99.1% |
Latest transcript on Blueprint Medicines Corporation
1 day | -1.43% | ||
1 week | -1.23% | ||
Current month | +15.38% | ||
1 month | +19.24% | ||
3 months | +15.49% | ||
6 months | +65.54% | ||
Current year | +14.25% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 04/01/16 |
Alexis Borisy
FOU | Founder | 52 | 30/09/08 |
Director of Finance/CFO | 52 | 31/08/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 13/04/16 |
Alexis Borisy
FOU | Founder | 52 | 30/09/08 |
Lonnel Coats
BRD | Director/Board Member | 58 | 03/02/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
17/05/24 | 105.2 | -1.37% | 159 119 |
16/05/24 | 106.6 | -0.14% | 411,483 |
15/05/24 | 106.8 | +1.26% | 758,088 |
14/05/24 | 105.5 | -2.40% | 582,058 |
13/05/24 | 108 | +1.27% | 383,987 |
Delayed Quote Nasdaq, May 17, 2024 at 06:51 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.25% | 6.68B | |
+34.10% | 50.85B | |
+0.31% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.94% | 26.11B | |
-21.98% | 19.13B | |
+8.86% | 13.05B | |
+27.13% | 12.16B | |
+24.55% | 12.08B |
- Stock Market
- Equities
- BPMC Stock